Form 4: Encompass Health Officer Plans Tax-Related Stock Sale

Encompass Health's Chief Accounting Officer, Andrew L. Price, filed a Form 4 detailing future stock dispositions to cover tax obligations from restricted stock vesting.

Summary

• Andrew L. Price, Chief Accounting Officer of Encompass Health Corp (EHC), filed a Form 4 reporting planned transactions under a Rule 10b5-1 plan.
• On February 19, 2026, 3,692 shares of Encompass Health Common Stock are scheduled to be disposed of at a price of $107.15 per share.
• On February 20, 2026, an additional 228 shares of Encompass Health Common Stock are scheduled to be disposed of at a price of $106.55 per share.
• These planned dispositions are to satisfy tax withholding obligations incurred in connection with the vesting of related restricted stock.
• Following these scheduled transactions, Mr. Price is expected to beneficially own 75,405 shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the planned share dispositions are for tax purposes related to equity compensation vesting, a common and expected occurrence for executives, especially when pre-arranged under a 10b5-1 plan.

Positives

• The transactions are part of a Rule 10b5-1 plan, indicating pre-scheduled, non-discretionary sales, which reduces concerns about opportunistic insider selling.
• The underlying vesting of restricted stock indicates continued executive alignment and performance-based compensation, suggesting retention of key management.

Negatives

• A planned reduction in direct beneficial ownership by 3,920 shares (3,692 + 228) upon the scheduled transaction dates.

Future Outlook

The filing indicates planned future transactions for February 2026, specifically the disposal of shares to cover tax withholding obligations related to restricted stock vesting under a Rule 10b5-1 plan.

Industry Context

StockSavvy.ai notes that routine insider sales for tax obligations upon restricted stock vesting, especially when pre-arranged under a Rule 10b5-1 plan, are common across industries and typically do not signal a change in management's outlook on the company's prospects. This is a standard practice for executive compensation management.

Stakeholder Impact

• Shareholders: A minor, pre-planned reduction in insider ownership, but the underlying vesting of restricted stock is a positive for executive retention and alignment with shareholder interests.

Key Dates

Recommendation

This Form 4 reports pre-scheduled, non-discretionary share dispositions under a Rule 10b5-1 plan to cover tax obligations from restricted stock vesting. Such routine transactions do not typically signal a change in the company's fundamentals or the insider's long-term view, thus a 'hold' recommendation is appropriate as no new material information impacting the investment thesis is presented.

Keywords

Encompass Health, EHC, Form 4, insider trading, stock sale, tax withholding, restricted stock, Andrew L. Price, Chief Accounting Officer, 10b5-1 plan